Upstate Clinical Research Associates

Summary

Upstate Clinical Research Associates is a medical facility located in Buffalo, New York. This center is recognized for care of Migraine, Vestibular Migraine, Chronic Pain, Osteoarthritis, Low Back Pain and other specialties. Upstate Clinical Research Associates is involved with conducting 67 clinical trials across 63 conditions. There are 1 research doctors associated with this hospital, such as James Wild, MD.

Top PIs

Clinical Trials running at Upstate Clinical Research Associates

Post-Traumatic Stress Disorder

Migraine

Vestibular Migraine

Neuropathic Pain

Cancer

Chronic Persistent Surgical Pain

Neuropathy

Fluoxetine

for PTSD

This is a Phase 2 randomized, double-blinded, placebo-controlled study that will evaluate multiple potential pharmacotherapeutic interventions for PTSD utilizing an adaptive platform trial design. Intervention A - Fluoxetine will assess the safety and efficacy of fluoxetine in participants with PTSD. Please see NCT05422612 for information on the S-21-02 Master Protocol.

Recruiting

0 awards

Phase 2

1 criteria

Daridorexant

for PTSD

This is a Phase 2 randomized, double-blinded, placebo-controlled study that will evaluate multiple potential pharmacotherapeutic interventions for PTSD utilizing an adaptive platform trial design. Intervention C - Daridorexant will assess the safety and efficacy of daridorexant in participants with PTSD. Please see NCT05422612 for information on the S-21-02 Master Protocol.

Recruiting

0 awards

Phase 2

1 criteria

New Treatments

for PTSD

This is a Phase 2 randomized, double-blinded, placebo-controlled study that will evaluate multiple potential pharmacotherapeutic interventions for PTSD utilizing an adaptive platform trial design. Participants are randomized among the multiple cohorts in the study and the resulting randomization enables sharing/pooling of control participants, where all interventions may be compared to a common control (placebo). This master protocol describes the default procedures and analyses for all cohorts; treatment-specific procedures will be described in the Master Protocol cohort-specific appendices. Individual cohorts may have additional eligibility requirements, safety and efficacy procedures, or endpoints, which will be described in corresponding intervention-specific clinicaltrials.gov records.

Recruiting

0 awards

Phase 2

6 criteria